Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute is a clinical research site located in Boston, Massachusetts, United States 02115.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute has participated in 1 clinical trials.
Therapeutic areas: Metastatic Renal Cell Carcinoma.
Sponsors: Antisoma Research.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma.
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.